Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-30 | Amended | $70,650 | $43,200 | Other | 06b | SEC link |
| 2024-07-16 | New | $6,000,000 | $6,000,000 | Debt Only | 06b | SEC link |
| 2024-02-23 | New | $6,000,000 | $6,000,000 | Debt Only | 06b | SEC link |
| 2023-03-22 | Amended | $27,450 | $9,450 | Other | 06b | SEC link |
| 2022-12-30 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2022-10-27 | New | $18,000 | $18,000 | Other | 06b | SEC link |
| 2020-09-14 | New | $2,500,000 | $2,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Pieter Burger | Director, Executive |
| John Hamer | Director |
| Thomas Kaiser | Director, Executive |
| Dennis Langer | Director |
| Christopher Meldrum | Director, Executive |